Literature DB >> 23040881

An association study of functional polymorphic genes IRF-1, IFNGR-1, and IFN-γ with disease progression, aspartate aminotransferase, alanine aminotransferase, and viral load in chronic hepatitis B and C.

May Korachi1, Nurgül Ceran, Riza Adaleti, Adil Nigdelioglu, Mehmet Sökmen.   

Abstract

BACKGROUND: Investigational approaches based on genome-wide association studies have proven useful in identifying genetic predictors for many diseases, including susceptibility to chronic hepatitis B and C. In these studies, the majority of genetic variants that have shown a positive association have been identified in genes involved in the immune response. In this study IFN-γ, IFNGR-1, and IRF-1 genes were analyzed for their role in susceptibility to the development of chronic hepatitis B and chronic hepatitis C in a Turkish population.
METHODS: Polymorphic genes IRF-1 (-410, -388), IFNGR-1 (-56, -611), and IFN-γ (+874) were analyzed in a total of 400 individuals: 100 chronic hepatitis B patients, 100 hepatitis B carriers, 100 chronic hepatitis C patients, and 100 healthy controls. A single base primer extension assay was used. Correlations between genes and gender, viral load, and aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels were also investigated.
RESULTS: The IRF-1 gene at positions -388 and -410 were observed to be candidate gene markers for susceptibility to the development of chronic hepatitis B and C (p<0.05). IFN-γ +874 and IFNGR-1 (-56 and -611) correlated with chronic hepatitis B but not chronic hepatitis C. Correlation of functional genotype with viral load and AST and ALT levels revealed an association of IFN-γ +874 and IFNGR-1 -611 with chronic hepatitis C and IFN-γ +874 with viral load and chronic hepatitis B (p<0.05).
CONCLUSIONS: Findings suggest that IFN-γ (+874), IRF-1 (-410, -388), and IFNGR-1 (-56, -611) are candidate gene markers for determining patient susceptibility to the development of chronic hepatitis B and C.
Copyright © 2012 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23040881     DOI: 10.1016/j.ijid.2012.08.004

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  13 in total

Review 1.  The interferon regulatory factors as novel potential targets in the treatment of cardiovascular diseases.

Authors:  Xiao-Jing Zhang; Ding-Sheng Jiang; Hongliang Li
Journal:  Br J Pharmacol       Date:  2015-02-27       Impact factor: 8.739

2.  Tumor Suppressor Interferon-Regulatory Factor 1 Counteracts the Germinal Center Reaction Driven by a Cancer-Associated Gammaherpesvirus.

Authors:  Wadzanai P Mboko; Horatiu Olteanu; Avijit Ray; Gang Xin; Eric J Darrah; Suresh N Kumar; Joseph M Kulinski; Weiguo Cui; Bonnie N Dittel; Stephen B Gauld; Vera L Tarakanova
Journal:  J Virol       Date:  2015-12-30       Impact factor: 5.103

3.  New Gene Variants Associated with the Risk of Chronic HBV Infection.

Authors:  Mengjie Fan; Jing Wang; Sa Wang; Tengyan Li; Hong Pan; Hankui Liu; Huifang Xu; Daria V Zhernakova; Stephen J O'Brien; Zhenru Feng; Le Chang; Erhei Dai; Jianhua Lu; Hongli Xi; Yanyan Yu; Jianguo Zhang; Binbin Wang; Zheng Zeng
Journal:  Virol Sin       Date:  2020-04-15       Impact factor: 4.327

Review 4.  Relationship between cytokine gene polymorphisms and chronic hepatitis B virus infection.

Authors:  Semra Tunçbilek
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

5.  Interferon gamma polymorphisms and hepatitis B virus-related liver cirrhosis risk in a Chinese population.

Authors:  Yifan Sun; Yu Lu; Li Xie; Yan Deng; Shan Li; Xue Qin
Journal:  Cancer Cell Int       Date:  2015-03-31       Impact factor: 5.722

6.  Interferon Gamma +874T/A Polymorphism Increases the Risk of Hepatitis Virus-Related Diseases: Evidence from a Meta-Analysis.

Authors:  Yifan Sun; Yu Lu; Taijie Li; Li Xie; Yan Deng; Shan Li; Xue Qin
Journal:  PLoS One       Date:  2015-05-04       Impact factor: 3.240

7.  Investigation into the effects of antioxidant-rich extract of Tamarindus indica leaf on antioxidant enzyme activities, oxidative stress and gene expression profiles in HepG2 cells.

Authors:  Nurhanani Razali; Azlina Abdul Aziz; Chor Yin Lim; Sarni Mat Junit
Journal:  PeerJ       Date:  2015-10-01       Impact factor: 2.984

8.  Polymorphism of IFN-γ (+874 T/A) in Syrian patients with chronic hepatitis B.

Authors:  Mohamad Al Kadi; Fawza Monem
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2017

9.  A gene variation of Interferon Gamma Receptor-I promoter (rs1327474A>G) and chronic hepatitis C virus infection.

Authors:  Maryam Karkhane; Seyed Reza Mohebbi; Afsaneh Sharifian; Amir Ghaemi; Hamid Asadzadeh Aghdaei; Mohammad Reza Zali
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2019

10.  Association of genetic polymorphisms in interferon-γ, interleukin-6 and transforming growth factor-β1 gene with oral lichen planus susceptibility.

Authors:  Maha Ali M Al-Mohaya; Lubna Al-Otaibi; Fahad Al-Harthi; Ebtissam Al Bakr; Misbahul Arfin; Abdulrahman Al-Asmari
Journal:  BMC Oral Health       Date:  2016-08-20       Impact factor: 2.757

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.